A New Drug For A Relentless Brain Disease

A New Drug For A Relentless Brain Disease

Up next

Coffee is complex. Can science standardize it for the better?

Ask any coffee aficionado, and they’ll tell you: A good cup is about more than the beans. The flavor is affected by lots of things – the roast and fermentation of the beans, the coarseness of the grind, the brewing temperature and even the chemicals in the water used to brew it. ...  Show more

NASA is practicing moonwalks. When are we going back?

After the success of Artemis II, we at Short Wave definitely have moon fever. So, we brought NPR science correspondent Nell Greenfieldboyce onto the show to talk about where we’re headed. What will future Artemis missions look like and what needs to happen next for people to be a ...  Show more

Recommended Episodes

Declining ALS Patients Are Waiting On The FDA's Next Move
Big Take

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Show more

Prognosis, a New Show From Bloomberg
Prognosis: Misconception

Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing ...  Show more

101: Have we found a cure for Alzheimer's, Parkinson's, Depression and ALS? | Dr. Jay Lombard
The Neuro Experience

If you’ve ever “gone with your gut” to make a decision or felt “butterflies in your stomach” when nervous, you’re likely getting signals from an unexpected source: your second brain. Hidden in the walls of the digestive system, this “brain in your gut” is revolutionizing medicine ...  Show more

The Promise of a New Treatment
Prognosis: Misconception

The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ...  Show more